Vimarsana
Biggest News Aggregation in the World

Page 2 - Rob Armstrong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Armstrong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Armstrong Today - Breaking & Trending Today

Lessons From The Gridiron: Using Data Insights To Win In Marketing - Vimarsana News

Lessons From The Gridiron: Using Data Insights To Win In Marketing

Moving from data reporting to data-driven decision-making can be a win-win for you and your customers.

Source: forbes.com
Artax announces first patient dosed in psoriasis treatment trial - Vimarsana News

Artax announces first patient dosed in psoriasis treatment trial

Artax Biopharma, a clinical-stage biotech company focused on transforming the treatment of autoimmune diseases, has dosed the first patient in its phase 2a trial evaluating oral, small molecule, AX-158 for the treatment of psoriasis.

Brenda Lucas: Community News Column for Saturday, February 17, 2024 - Vimarsana News

Brenda Lucas: Community News Column for Saturday, February 17, 2024

TASTING: Indulge in a delightful evening of decadence at the chocolate wine tasting and decide for yourself how the two go together at 5:30 p.m. Monday, Feb. 19, at The

Artax announces first patient dosed in psoriasis treatment trial - Vimarsana News

Artax announces first patient dosed in psoriasis treatment trial

Artax Biopharma, a clinical-stage biotech company focused on transforming the treatment of autoimmune diseases, has dosed the first patient in its phase 2a trial evaluating oral, small molecule, AX-158 for the treatment of psoriasis.

Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158 - Vimarsana News

Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158

/PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces...